Cargando…
Circulating miRNAs can serve as potential diagnostic biomarkers in chronic myelogenous leukemia patients
INTRODUCTION: Chronic Myelogenous Leukemia (CML) is a myeloproliferative disorder described as a malignant blood disorder by accounts for 15–20% of all adult leukemia. MicroRNAs (miRNAs) play an important role in post-transcriptional regulation of gene expressions. Expression level of tumor suppress...
Autores principales: | Keramati, Farid, Jafarian, Arefeh, Soltani, Adele, Javandoost, Ehsan, Mollaei, Mojtaba, Fallah, Parviz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355908/ https://www.ncbi.nlm.nih.gov/pubmed/34401317 http://dx.doi.org/10.1016/j.lrr.2021.100257 |
Ejemplares similares
-
Targeting Myelogenous Leukemia Stem Cells: Role of the Circulation
por: Liesveld, Jane
Publicado: (2012) -
The microRNAs involved in human myeloid differentiation and myelogenous/myeloblastic leukemia
por: Wang, Xiao-Shuang, et al.
Publicado: (2008) -
Chronic myelogenous leukemia in Libya
por: Mehdi, Itrat, et al.
Publicado: (2012) -
Chronic myelogenous leukemia on target
por: Némethová, Veronika, et al.
Publicado: (2018) -
Prodigiosin induced the caspase-dependent apoptosis in human chronic myelogenous leukemia K562 cell
por: Niakani, Maryam, et al.
Publicado: (2020)